Non-Alcoholic fatty liver disease (NAFLD) and Cardiovascular Risk: Is Imaging helpful?

Authors

Stavros A. Doumas, Georgetown University Medical Center, Washington, DC, USA.
Shalini Tripathi, Carolina East Medical Center, New Bern, NC, USA.
Aditi Kashikar, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Akhilesh Khuttan, Carolina East Medical Center, New Bern, NC, USA.
Ashwin Kumar, Georgetown University Medical Center, Washington, DC, USA.
Harjit Singh, Georgetown University Medical Center, Washington, DC, USA.
Justin P. Canakis, George Washington University, Washington, DC, USA.
Kumar Ashish, Carolina East Medical Center, New Bern, NC, USA.
Debashish Dey, Vidyasagar University, India; National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Ian Oppenheim, Georgetown University Medical Center, Washington, DC, USA.
Amit Kumar Dey, Georgetown University Medical Center, Washington, DC, USA; National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: Amit4kem@gmail.com.

Document Type

Journal Article

Publication Date

8-29-2023

Journal

Current problems in cardiology

DOI

10.1016/j.cpcardiol.2023.102065

Keywords

NAFLD; cardiovascular; imaging

Abstract

NAFLD is proving to be a globally prevalent condition and is on the rise. Moreover, NAFLD might be an independent risk factor associated with higher CVD morbidity and mortality. More studies need to assess whether NAFLD needs to be included in the atherosclerotic risk score algorithms or whether patients with NAFLD need to be screened early on to assess their CVD risk especially since imaging such as positron emission tomography can be used to assess both NAFLD and CV disease at the same time. Hence, employing cardiovascular imaging modalities to investigate the incidence, extent and nature of atherosclerotic lesions In NAFLD may be beneficial. Additionally, whether treating NAFLD halts the progression of CAD on imaging remains to be seen. Further research to delineate NAFLD and CVD associations, deciphering screening imaging modalities and investigating targeted interventions could improve CVD morbidity and mortality in NAFLD.

APA Citation

Doumas, Stavros A.; Tripathi, Shalini; Kashikar, Aditi; Khuttan, Akhilesh; Kumar, Ashwin; Singh, Harjit; Canakis, Justin P.; Ashish, Kumar; Dey, Debashish; Oppenheim, Ian; and Dey, Amit Kumar, "Non-Alcoholic fatty liver disease (NAFLD) and Cardiovascular Risk: Is Imaging helpful?" (2023). GW Authored Works. Paper 3196.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/3196

Department

School of Medicine and Health Sciences Resident Works